“Our vision at Quantumzyme is to help reshape the future of industrial chemistry through the power of enzymatic catalysis,” stated Naveen Kulkarni, CEO of Quantumzyme. “By combining AI and ...

Quantumzyme Corporation (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is exploring innovative solutions in next-generation biocatalysis. By integrating AI-driven ...

Ginkgo Bioworks gains a $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems.

The Global Biocatalyst Market is valued at approximately USD 1.17 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.67% over the forecast period 2024-2032. Read the ...

One of the most significant challenges facing current nanozyme technologies is the lack of well-defined active sites, which ...

As Independent Director, Manu Bharath Khareedhi will play a pivotal role in guiding Quantumzyme’s long-term strategy, focusing on: Expanding global partnerships to drive the adoption of sustainable ...

Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to introduce Manu Bharath Khareedhi as an Independent Member of its Board ...